Description

Non-coding RNAs (ncRNAs) have emerged as key regulators of gene expression and cellular function, challenging the traditional view that protein-coding genes are the primary drivers of biological activity. Among the most studied ncRNAs are microRNAs (miRNAs), long non-coding RNAs (lncRNAs), small interfering RNAs (siRNAs) and circular RNAs (circRNAs), each with distinct mechanisms of action. miRNAs, typically 20â??24 nucleotides long, regulate gene expression post-transcriptionally by binding to complementary sequences on target mRNAs, leading to degradation or translational repression. siRNAs mediate sequence-specific mRNA degradation and are widely used as experimental tools for gene silencing. Circular RNAs, generated by back-splicing events, act as microRNA sponges or regulate transcription and protein activity. The study of ncRNAs thus provides a deeper understanding of molecular regulation beyond protein-coding genes [2].

MicroRNAs play a pivotal role in fine-tuning gene expression and are involved in nearly every aspect of cellular physiology. They participate in cell cycle regulation, differentiation, apoptosis and stress response by targeting multiple mRNAs simultaneously. In cardiovascular diseases, miRNAs modulate processes such as angiogenesis, cardiac hypertrophy and fibrosis. In neurological disorders, altered miRNA expression affects synaptic plasticity, neuronal survival and neuroinflammation. The ability of miRNAs to target multiple genes simultaneously underscores their central role in coordinating cellular networks. Therapeutically, miRNA mimics or inhibitors are being explored to restore normal gene expression in disease contexts. Furthermore, circulating miRNAs are being investigated as minimally invasive biomarkers for early disease detection and prognosis. Overall, miRNAs serve as critical molecular switches that maintain cellular balance and respond dynamically to internal and external cues [3].

Long non-coding RNAs (lncRNAs) are versatile regulators of gene expression with diverse mechanisms, including chromatin modification, transcriptional regulation and post-transcriptional control. They can recruit chromatin-modifying complexes to specific genomic loci, influencing epigenetic states and gene expression patterns. Some lncRNAs act as molecular scaffolds that bring together proteins and RNA molecules, facilitating complex formation and signaling. Others function as decoys or sponges that sequester transcription factors, miRNAs, or other regulatory molecules, thereby modulating their availability. Dysregulation of lncRNAs has been associated with cancer, where they can promote tumor growth, invasion and resistance to therapy. In metabolic and cardiovascular diseases, lncRNAs regulate lipid metabolism, vascular function and inflammatory responses. In neurological disorders, they contribute to synaptic function, neuronal differentiation and neurodegenerative pathways. Advances in high-throughput sequencing and bioinformatics have greatly expanded the catalog of functional lncRNAs and revealed their tissue- and context-specific roles. This growing body of evidence highlights the critical importance of lncRNAs in both normal physiology and disease development [4].

Other ncRNAs, including circRNAs and siRNAs, also play significant roles in cellular regulation and disease. CircRNAs are stable, covalently closed RNA molecules that often act as microRNA sponges, modulating miRNA availability and downstream gene expression. siRNAs, though primarily studied as experimental tools, reflect natural RNA interference mechanisms that maintain genomic stability and control viral infections. Together, these ncRNAs form interconnected regulatory networks that fine-tune gene expression, maintain cellular homeostasis and adapt to environmental changes. Disruption of these networks can trigger aberrant signaling, contributing to pathologies such as tumorigenesis, neurodegeneration and chronic inflammatory conditions. Research into ncRNAs has not only expanded our understanding of molecular regulation but has also highlighted their potential as diagnostic biomarkers and therapeutic targets. As technologies advance, the exploration of ncRNAs promises to revolutionize both basic biology and clinical medicine [5].

Conclusion

Non-coding RNAs are central regulators of gene expression, orchestrating complex networks that control cellular processes such as proliferation, differentiation, apoptosis and stress response. Their dysregulation contributes to the development and progression of numerous diseases, including cancer, neurodegenerative disorders, cardiovascular conditions and immune-related pathologies. Understanding the molecular mechanisms of ncRNA function has not only advanced fundamental biology but also revealed their potential as diagnostic biomarkers and therapeutic targets. Ongoing research into ncRNAs promises to transform precision medicine, enabling the development of targeted therapies that modulate specific regulatory pathways. Advances in RNA-based therapeutics, high-throughput sequencing and bioinformatics will enhance the ability to identify, characterize and manipulate disease-associated ncRNAs. Integrating ncRNA insights with personalized medicine approaches could offer highly specific interventions, improving treatment efficacy and patient outcomes while opening new avenues for disease prevention and management.<./p>

Acknowledgment

None.

Conflict of Interest

None.

Reference

1. Blagih J, Buck MD, Vousden KH (2020). p53, cancer and the immune response. J Cell Sci 133: jcs237453.

                     Google Scholar Cross Ref Indexed at

2. Alvarado-Ortiz E, de la Cruz-López KG, Becerril-Rico J, Sarabia-Sánchez MA, Ortiz-Sánchez E, et al. (2021). Mutant p53 gain-of-function: role in cancer development, progression, and therapeutic approaches. Front Cell Dev Biol 8: 607670.

                     Google Scholar Cross Ref Indexed at

3. Kuang D, Zhang X, Hua S, Dong W, Li Z (2016). Long non-coding RNA TUG1 regulates ovarian cancer proliferation and metastasis via affecting epithelial-mesenchymal transition. Exp Mol Pathol 101(2), 267-273.

                     Google Scholar Cross Ref Indexed at

4. Zou A, Liu R, Wu X (2016). Long non-coding RNA MALAT1 is up-regulated in ovarian cancer tissue and promotes SK-OV-3 cell proliferation and invasion. Neoplasma 63: 865-872.

                       Google Scholar Cross Ref Indexed at

5. Long X, Song K, Hu H, Tian Q, Wang W, et al. (2019). Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. J Exp Clin Cancer Res 38(1), 345.

                      Google Scholar Cross Ref Indexed at